Primary treatment and prognostic factors of small cell neuroendocrine carcinoma of the uterine cervix: A Taiwanese Gynecologic Oncology Group study

European Journal of Cancer

Volumn 48, Issue 10, 2012, Pages 1484-1494

  Wang, Kung Liahng ^a,k,l   Chang, Ting Chang ^b   Jung, Shih Ming ^b   Chen, Chi Hau ^c   Cheng, Ya Min ^d   Wu, Hua Hsi ^e   Liou, Wen Shiung ^f   Hsu, Shih Tien ^g   Ou, Yu Che ^b   Yeh, Lian Shung ^h   Lai, Hung Cheng ⁱ   Huang, Chia Yen ^j   Chen, Tze Chien ^a   Chang, Chee Jen ^b   Lai, Chyong Huey ^b  

^a MACKAY MEMORIAL HOSPITAL   (Taiwan)

^b CHANG GUNG UNIVERSITY   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^d NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^e NATIONAL YANG MING UNIVERSITY   (Taiwan)

^f KAOHSIUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^g TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^h CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

ⁱ NATIONAL DEFENSE UNIVERSITY   (Taiwan)

^j CATHAY GENERAL HOSPITAL   (Taiwan)

^k NURSING AND MANAGEMENT COLLEGE   (Taiwan)

^l TAIPEI MEDICAL UNIVERSITY   (Taiwan)

more..

Author keywords

Cervical carcinoma; Chemoradiation; Chemotherapy; Prognosis; Small cell neuroendocrine carcinoma

Indexed keywords

ETOPOSIDE; PLATINUM;

ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER PROGNOSIS; CANCER SPECIFIC SURVIVAL; CANCER STAGING; CANCER SURGERY; CHEMORADIOTHERAPY; FAILURE FREE SURVIVAL; FEMALE; HUMAN; INTERMETHOD COMPARISON; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; NEUROENDOCRINE TUMOR; PRIORITY JOURNAL; SMALL CELL CARCINOMA; SMALL CELL NEUROENDOCRINE CERVICAL CARCINOMA; TAIWAN; TREATMENT OUTCOME; UTERINE CERVIX CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SMALL CELL; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LYMPHATIC METASTASIS; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM METASTASIS; PROGNOSIS; REGISTRIES; RETROSPECTIVE STUDIES; TAIWAN; TIME FACTORS; TREATMENT OUTCOME; UTERINE CERVICAL NEOPLASMS;

EID: 84862819949     PISSN: 09598049     EISSN: 18790852     Source Type: Journal    
DOI: 10.1016/j.ejca.2011.12.014     Document Type: Article

References (32)

1. J.W. Reagan, M.J. Hamonic, and W.B. Wentz Analytical study of the cells in cervical squamous-cell cancer Lab Invest 6 1957 241 250
2. J. Albores-Saavedra, D. Gersell, and B. Gilk Terminology of endocrine tumors of the uterine cervix Arch Pathol Lab Med 121 1997 34 39
3. J.C. Yao, M. Hassan, and A. Phan One hundred years after "carcinoid": epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States J Clin Oncol 26 2008 3063 3072
4. S. Crowder, and E. Tuller Small cell carcinoma of the female genital tract Semin Oncol 34 2007 57 63
5. T.C. Chang, C.H. Lai, C.J. Tseng, K.G. Huang, and H.H. Chou Prognostic factors in surgically treated small cell carcinoma followed by adjuvant chemotherapy Cancer 83 1998 712 718
6. K.L. Wang, Y.C. Yang, and T.Y. Wang Neuroendocrine carcinoma of the uterine cervix: a clinicopathologic retrospective study of 31 cases with prognostic implications J Chemother 18 2006 209 216
7. T.C. Chang, S. Hsueh, C.H. Lai, K.G. Huang, and H.H. Chou Phase II trial of neoadjuvant chemotherapy in early-stage small cell cervical cancer Anti-cancer Drugs 10 1999 641 646
8. O. Zivanovic, M.M. Leitao Jr., and K.J. Park Small cell neuroendocrine carcinoma of the cervix: analysis of outcome, recurrence pattern and the impact of platinum-based combination chemotherapy Gynecol Oncol 112 2009 590 593
9. P.J. Hoskins, K.D. Swenerton, and J.A. Pike Small-cell carcinoma of the cervix: fourteen years of experience at a single institution using a combined-modality regimen of involved-field irradiation and platinum-based combination chemotherapy J Clin Oncol 21 2003 3495 3501
10. J.M. Lee, K.B. Lee, and J.H. Nam Prognostic factors in FIGO stage IB-IIA small cell neuroendocrine carcinoma of the uterine cervix treated surgically: results of a multi-center retrospective Korean study Ann Oncol 19 2008 321 326
11. A.N. Viswanathan, M.T. Deavers, and A. Jhingran Small cell neuroendocrine carcinoma of the cervix: outcome and patterns of recurrence Gyncol Oncol 93 2004 27 33
12. T. Kasamatsu, Y. Sasajima, and T. Onda Surgical treatment for neuroendocrine carcinoma of the cervix Int J Gynecol Obstet 99 2007 225 228
13. J.K. Chan, V. Loizzi, R.A. Burger, J. Rutgers, and B.J. Monk Prognostic factors in neuroendocrine small cell cervical carcinoma: a multivariate analysis Cancer 97 2003 568 574
14. J.G. Cohen, D.S. Kapp, and J.Y. Shin Small cell carcinoma of the cervix: treatment, survival outcomes of 188 patients Am J Obstet Gynecol 203 2010 347.e1-6
15. C.Y. Huang, Y.L. Chen, and T.C. Chu Prognostic factors in women with early stage small cell carcinoma of the uterine cervix Oncol Res 18 2009 279 286
16. P.H. Wang, Y.C. Liu, and C.R. Lai Small cell carcinoma of the cervix: analysis of clinical and pathological findings Eur J Gynecol Oncol 19 1998 189 192
17. J. Chen, K. Macdonald, and D.K. Gaffney Incidence, mortality and prognostic factors of small cell carcinoma of the cervix Obstet Gynecol 111 2008 1394 1402
18. S. Tsunoda, T. Jobo, and M. Arai Small-cell carcinoma of the uterine cervix: a clinicopathologic study of 11 cases Int J Gynecol Cancer 15 2005 295 300
19. V.M. Abeler, R. Holm, J.M. Nesland, and K.E. Kjorstad Small cell carcinoma of the cervix. A clinicopathologic study of 26 patients Cancer 73 1994 672 677
20. S. Sundstrom, R.M. Bremnes, and S. Kaasa Cisplatin and etoposide regimen is superior to cyclophosphamide, epirubicin, and vincristine regimen in small-cell lung cancer: results from a randomized phase III trial with 5 years' follow-up J Clin Oncol 20 2002 4665 4672
21. K. Noda, Y. Nishiwaki, and M. Kawahara Irinotecan plus cisplatin compared with etoposide plus cisplatin for extensive small-cell lung cancer New Engl J Med 346 2002 85 91
22. N. Hanna, P.A. Bunn Jr, and C. Langer Randomized phase III trial comparing irinotecan/cisplatin with etoposide/cisplatin in patients with previously untreated extensive-stage disease small-cell lung cancer J Clin Oncol 24 2006 2038 2043
23. A. Hermes, B. Bergman, and R. Bremnes Irinotecan plus carboplatin versus oral etoposide plus carboplatin in extensive small-cell lung cancer: a randomized phase III trial J Clin Oncol 26 2008 4261 4267
24. R. Govindan, N. Page, and D. Morgensztern Changing epidemiology of small-cell lung cancer in the United States over the last 30 years: analysis of the Surveillance, Epidemiologic, and End Results database J Clin Oncol 24 2006 4539 4544
25. T. Binderup, U. Knigge, A. Loft, B. Federspiel, and A. Kjaer 18F-fluorodeoxyglucose positron emission tomography predicts survival of patients with neuroendocrine tumors Clin Cancer Res 16 2010 978 995
26. J.L. Pujol, J.L. Breton, and R. Gervais Phase III double-blind, placebo-controlled study of thalidomide in extensive-disease small-cell lung cancer after response to chemotherapy: an intergroup study FNCLCC cleo04-IFCT 00-01 J Clin Oncol 25 2007 3945 3951
27. A.M. Arnold, L. Seymour, and M. Smylie Phase II study of vandetanib or placebo in small-cell lung cancer patients after complete or partial response to induction chemotherapy with or without radiation therapy: National Cancer Institute of Canada Clinical Trials Group study BR.20 J Clin Oncol 25 2007 4278 4284
28. D.R. Spigel, P.M. Townley, and D.M. Waterhouse Randomized phase II study of bevacizumab in combination with chemotherapy in previously untreated extensive-stage small-cell lung cancer: results from the SALUTE trial J Clin Oncol 29 2011 2215 2222
29. D.R. Spigel, F.A. Greco, and J.D. Zubkus Phase II trial of irinotecan, carboplatin, and bevacizumab in the treatment of patients with extensive-stage small-cell lung cancer J Thorac Oncol 4 2009 1555 1560
30. R. Jotte, P. Conkling, and C. Reynolds Randomized phase II trial of single-agent amrubicin or topotecan as second-line treatment in patients with small-cell lung cancer sensitive to first-line platinum-based chemotherapy J Clin Oncol 29 2011 287 293
31. G.J. Gardner, D. Reidy-Lagunes, and P.A. Gehrig Neuroendocrine tumors of the gynecologic tract: a Society of Gynecologic Oncology (SGO) clinical document Gynecol Oncol 122 2011 190 198
32. M.H. Kulke, L.L. Siu, and J.E. Tepper Future directions in the treatment of neuroendocrine tumors: consensus report of the national cancer institute neuroendocrine tumor clinical trials planning meeting J Clin Oncol 29 2011 934 943